Trial intelligence / Profile preview

Pilot Study in Cancer Patients Scheduled for Surgery Evaluating Different Smoking Cessation Protocols

NCT04899492Terminated

Sponsor
Institut Cancérologique de l'Ouest
Start
Sep 2021
Primary completion
Mar 2024
Countries
1
01

Overview

Randomised, open-label trial (4 arms), sponsored by Institut Cancérologique de l'Ouest. Primary endpoint: Feasibility of Smoking Cessation Interventions Evaluated in French Cancer Patients Undergoing Surgery at 12 months. Started Sep 2021; status: terminated.

Beyond the preview

Go deeper on NCT04899492.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04899492.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call